Energenesis Biomedical CO.,LTD. (TPE:6657)
38.60
+0.30 (0.78%)
May 29, 2026, 1:30 PM CST
TPE:6657 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 580.63 | 673.1 | 404.51 | 246.61 | 90.2 | 149.37 |
Short-Term Investments | 195 | 165 | 260.47 | 452.59 | 394.47 | 576.47 |
Cash & Short-Term Investments | 775.63 | 838.1 | 664.98 | 699.2 | 484.67 | 725.84 |
Cash Growth | -23.11% | 26.03% | -4.89% | 44.26% | -33.23% | 33.45% |
Accounts Receivable | 0.76 | 1.39 | 0.85 | 0.93 | 1.53 | 1.31 |
Other Receivables | 2.84 | 18.69 | 16.96 | 14.63 | 11.48 | 8.7 |
Receivables | 3.59 | 20.08 | 17.81 | 15.56 | 13.01 | 10.01 |
Inventory | 0.83 | 0.9 | 0.75 | 0.73 | 0.59 | 0.69 |
Prepaid Expenses | 21.78 | 5.32 | 4.17 | 3.92 | 5.18 | 3.42 |
Other Current Assets | 0.03 | 0.02 | 0.04 | 0.04 | 0.04 | 0.03 |
Total Current Assets | 801.87 | 864.43 | 687.75 | 719.44 | 503.49 | 739.98 |
Property, Plant & Equipment | 77.32 | 78.72 | 75.79 | 77.22 | 82.51 | 89.02 |
Other Intangible Assets | 0.01 | 1.06 | 13.67 | 26.32 | 38.96 | 51.48 |
Other Long-Term Assets | 4.56 | 4.77 | 3.43 | 5.59 | 5.9 | 5.32 |
Total Assets | 883.76 | 948.98 | 780.64 | 828.57 | 630.86 | 885.81 |
Accounts Payable | 0.06 | 0.39 | 0.31 | 0.34 | 0.37 | 0.3 |
Accrued Expenses | - | 31.49 | 27.07 | 12.47 | 13.88 | 12.41 |
Current Portion of Leases | 5.22 | 5.55 | 4.56 | 5.04 | 5.59 | 5.75 |
Current Unearned Revenue | 0.02 | - | - | - | - | - |
Other Current Liabilities | 21.31 | 5.99 | 3.9 | 3.5 | 4.52 | 8.8 |
Total Current Liabilities | 26.61 | 43.42 | 35.83 | 21.34 | 24.36 | 27.24 |
Long-Term Leases | 8.07 | 9.29 | 5.47 | 3.24 | 3.95 | 6.19 |
Total Liabilities | 34.68 | 52.71 | 41.31 | 24.59 | 28.31 | 33.44 |
Common Stock | 888.08 | 888.08 | 764.94 | 760.25 | 668.45 | 663.71 |
Additional Paid-In Capital | 536.35 | 534.09 | 64.62 | 393.9 | 199.77 | 307.62 |
Retained Earnings | -535.79 | -489.48 | -231.08 | -350.67 | -265.66 | -120.24 |
Treasury Stock | -39.59 | -36.35 | - | - | - | - |
Comprehensive Income & Other | 0.02 | -0.07 | 140.85 | 0.5 | - | 1.29 |
Shareholders' Equity | 849.07 | 896.27 | 739.33 | 803.98 | 602.56 | 852.38 |
Total Liabilities & Equity | 883.76 | 948.98 | 780.64 | 828.57 | 630.86 | 885.81 |
Total Debt | 13.3 | 14.84 | 10.03 | 8.28 | 9.54 | 11.94 |
Net Cash (Debt) | 762.33 | 823.26 | 654.95 | 690.92 | 475.13 | 713.91 |
Net Cash Growth | -23.43% | 25.70% | -5.21% | 45.41% | -33.45% | 34.96% |
Net Cash Per Share | 8.67 | 9.31 | 8.58 | 9.59 | 7.13 | 11.89 |
Filing Date Shares Outstanding | 87.98 | 87.98 | 76.49 | 76.03 | 66.85 | 66.37 |
Total Common Shares Outstanding | 87.98 | 87.98 | 76.49 | 76.03 | 66.85 | 66.37 |
Working Capital | 775.26 | 821.01 | 651.91 | 698.1 | 479.12 | 712.74 |
Book Value Per Share | 9.65 | 10.19 | 9.67 | 10.58 | 9.01 | 12.84 |
Tangible Book Value | 849.06 | 895.21 | 725.66 | 777.67 | 563.59 | 800.89 |
Tangible Book Value Per Share | 9.65 | 10.18 | 9.49 | 10.23 | 8.43 | 12.07 |
Land | - | 54.03 | 54.03 | 54.03 | 54.03 | 54.03 |
Buildings | - | 7.06 | 7.06 | 7.06 | 7.06 | 7.06 |
Machinery | - | 27.58 | 26.01 | 25.26 | 24.91 | 24.26 |
Leasehold Improvements | - | 5.13 | 5 | 5 | 5 | 5 |